Biotechnology News

September 27, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today announced that oral arguments are scheduled for November 6, 2012, in Washington, D.C. in connection with the University of California, San Francisco’s (UCSF) appeal...

September 27, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Medical information call centers require the proper headcounts and necessary budgets to provide essential support to physicians and patients, according to a new study by Cutting Edge Information.

September 27, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new study finds that growing companies dealing with larger portfolios tend to decentralize their regulatory affairs groups in pursuit of geographic or therapeutic specialization.

September 27, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical drug development company, announced today that it has signed a purchase agreement for the sale, from time to time, of up to $15 million of its American...

September 27, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB: ORGS) (“Orgenesis” or “the Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

September 27, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ:PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced Italian export company TICE as its general sales agent and distributor for Italy. Dosolino...

September 27, 2012

TORONTO--(BUSINESS WIRE)--The aging population of Europe, coupled with greater use of premium-priced transcatheter heart valve (THV) devices will enable the European heart valve market to grow at 10 percent per year.

September 27, 2012

SEATTLE--(BUSINESS WIRE)--NanoString has obtained the CE Mark for its PAM50-based gene expression test for breast cancer, clearing the company to sell its test in the European Union and other countries recognizing the CE Mark.

September 27, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today the publication of results from the Phase II EAGLE clinical trial for BL-1020, a first in class, orally available, GABA-...

September 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome, Inc. is taking orders for knoSYS™100, the first plug-and-play, fully integrated hardware/software system to help researchers in medical and academic institutions interpret human whole genomes.

September 27, 2012

CUMBERLAND, R.I.--(BUSINESS WIRE)--Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the presentation of a scientific poster summarizing the...

September 27, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus (OTC BB PVCT) Expands Protocol For Phase 1 Liver Cancer Study

September 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced that CEO Frank Reynolds is scheduled to...

September 27, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Stem Cell Market Poised for Billion-Dollar Growth

September 27, 2012

GATWICK, England--(BUSINESS WIRE)--Launch of Gargrave Sterilisation Services for Gamma Irradiation and Laboratory services within healthcare from Systagenix

September 27, 2012

LONDON--(BUSINESS WIRE)--Today Janssen Healthcare Innovation (JHI), a team within Janssen Research & Development, LLC. (Janssen), announced the Janssen Connected Health Challenge Europe 2012 in partnership with Health 2.0. The Janssen...

September 27, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The French blood center organization EFS has in this tender chosen HLA typing products from Allenex (STO:ALNX). After a central evaluation, it is clear that the 17 transplant laboratories that are part...

September 26, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company(NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the New Drug Application (NDA)...

September 26, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Landec Corporation (NASDAQ: LNDC) today reported results for the first quarter of fiscal year 2013 ended August 26, 2012. Revenues increased 39% to $102.1 million compared to revenues of $73.3 million for the...

September 26, 2012

WASHINGTON & CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The fifth annual international partnering conference, BioPharm America™ 2012, wrapped up last week in Boston. There were over 750 delegates representing 462 companies from 30...

September 26, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), the body-worn device company, today announced it will be the supplier of hearing aids for hi HealthInnovations, a UnitedHealth Group company. UnitedHealthcare recently...

September 26, 2012

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has announced that its enhanced stent-delivery system for the Self-Apposing Stent has been released in Europe. The STENTYS stent solves complications resulting from inappropriate stent size....

September 26, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research Inc. offers Theorem Strategic Sourcing Solutions to provide staffing and outsourcing services to the pharmaceutical and biotech industries in more than 30 countries

September 26, 2012

MADISON, Wis.--(BUSINESS WIRE)--Stealth Therapeutics announced that its Invisiport has been implanted in a patient for the first time, an 18 year-old from northern California.

September 26, 2012

MONTREAL--(BUSINESS WIRE)--Angiochem, a clinical stage biotechnology company, today announced presentations at six upcoming biotechnology conferences: Boulder Peptide symposium, September 26-28, 2012, Boulder, CO Jean E. Lachowicz Ph.D., Chief...

September 26, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that surveyed gastroenterologists and rheumatologists in the United States and Europe...

September 26, 2012

BERLIN--(BUSINESS WIRE)--NOXXON Pharma today announced the treatment of the first cohort of three multiple myeloma (MM) patients in a Phase IIa clinical trial of its anti-CXCL12/SDF-1 (CXC chemokine ligand 12 / Stromal Cell-Derived Factor-1)...

September 26, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced the 2012 team of inspirational athletes serving as PPD Heroes and competing in the PPD Beach2Battleship Triathlon on Oct. 20.

September 26, 2012

NEW YORK--(BUSINESS WIRE)--Accenture has completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry.

September 26, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Pharmaceutical brand teams eager to maximize the price of the drugs establish intricate product launch sequencing strategies to target markets more favorable to higher value assessments.

September 26, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has...

September 26, 2012

TORONTO--(BUSINESS WIRE)--The most significant growth in the BRIC peripheral vascular market will be in aortic stent grafts and lower extremity devices.

September 26, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2012 sales and earnings conference call with institutional investors and analysts at 8 a.m. EDT on Friday...

September 26, 2012

WESTON, Mass. and STOCKHOLM, Sweden--(BUSINESS WIRE)--Biogen Idec and Sobi announce positive top-line results from Phase 3 study investigating long-lasting recombinant Factor IX Fc fusion protein in hemophilia B

September 26, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Xdynia LLC President Yuri Maricich will speak at the 2012 Mid-Atlantic Bio Conference on developing T-type calcium channel inhibitors to treat chronic pain, chemotherapy-induced neuropathy, and tremor

September 26, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac is pleased to announce the successful inspection of its Clinical Services operations located in Craigavon by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The inspection,...

September 26, 2012

MANNHEIM, Germany--(BUSINESS WIRE)--At the annual conference of the DGKL (Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin –see www.dgkl.de), Bruker today announced...

September 26, 2012

OXFORD, England--(BUSINESS WIRE)--PsiOxus Therapeutics has treated its first patient in its phase I/II clinical trial of its oncolytic vaccine, ColoAd1, for the treatment of metastatic solid tumours.

September 25, 2012

YOKOHAMA, Japan--(BUSINESS WIRE)--Business Wire is the official media partner for the BioJapan 2012. Breaking news releases, online press kits are available at Tradeshownews.com.

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the U.S. District Court of the District of Massachusetts has ruled in favor of Alnylam and has denied...

September 25, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, held the initial...

September 25, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced the pricing of the offering of US$600 million aggregate principal amount of 6.250% Senior Notes due 2019 (“Notes”) by its wholly-owned subsidiaries, Elan Finance...

September 25, 2012

BETHESDA, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--U.S. Food and Drug Administration (FDA) grants priority review status to AMITIZA® (lubiprostone) submission seeking approval for treatment of opioid-induced constipation.

September 25, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Tegal Corp. changes name to CollabRx, Inc. Ticker to change on Sept. 27, 2012 to CLRX

September 25, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that it has successfully completed the refinancing of its previously outstanding senior secured bank debt and reduced the company’s overall debt outstanding from approximately $...

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Announces Presentation of Data at North American Cystic Fibrosis Conference

September 25, 2012

RICHMOND, Va.--(BUSINESS WIRE)--Jeffrey M. Gallagher has been named as the new CEO for the Virginia Biotechnology Association.

September 25, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) applauds Sens. Robert Menendez (D-NJ) and Olympia Snowe (R-ME) and Reps. Jim Gerlach (R-PA) and Richard Neal (D-MA) for introducing the High Technology Small Business...